scholarly journals Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer

2018 ◽  
Vol 10 (12) ◽  
pp. 505-515 ◽  
Author(s):  
Moon Jae Chung ◽  
Huapyong Kang ◽  
Ho Gak Kim ◽  
Jong Jin Hyun ◽  
Jun Kyu Lee ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Multicenter Phase ◽  
Gemcitabine Refractory

scholarly journals Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)

2013 ◽  
Vol 24 (10) ◽  
pp. 2576-2581 ◽  
Author(s):  
H. Fensterer ◽  
C. Schade-Brittinger ◽  
H.-H. Müller ◽  
S. Tebbe ◽  
J. Fass ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Adjuvant Therapy ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Safety And Efficacy ◽  
Multicenter Phase

scholarly journals Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer

2015 ◽  
Vol 112 (9) ◽  
pp. 1428-1434 ◽  
Author(s):  
S Ohkawa ◽  
T Okusaka ◽  
H Isayama ◽  
A Fukutomi ◽  
K Yamaguchi ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Gemcitabine Refractory

ACOSOG Z05031: Report on a multicenter, phase II trial for adjuvant therapy of resected pancreatic cancer using cisplatin, 5- FU, and alpha-interferon

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 4505-4505 ◽  
Author(s):  
V. J. Picozzi ◽  
R. A. Abrams ◽  
L. W. Traverso ◽  
E. M. O’Reilly ◽  
E. Greeno ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Adjuvant Therapy ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Alpha Interferon ◽  
Multicenter Phase

scholarly journals Randomized Phase II Trial of S-1 versus S-1 Plus Oxaliplatin (SOX) in Patients with Gemcitabine Refractory Pancreatic Cancer

2012 ◽  
Vol 23 ◽  
pp. ix241-ix242 ◽  
Author(s):  
T. Okusaka ◽  
S. Ohkawa ◽  
H. Isayama ◽  
A. Fukutomi ◽  
K. Yamaguchi ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Randomized Phase Ii ◽  
Gemcitabine Refractory

A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2

2013 ◽  
Vol 31 (5) ◽  
pp. 1294-1299 ◽  
Author(s):  
Yousuke Nakai ◽  
Hiroyuki Isayama ◽  
Hideaki Ijichi ◽  
Takashi Sasaki ◽  
Naminatsu Takahara ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Combination Therapy ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Pancreatic Cancer ◽  
Multicenter Phase
Sign in / Sign up

Export Citation Format

Share Document